Personal profile
Research interests
Onderzoeksbelangen
Fingerprint
Dive into the research topics where Lieve Tytgat is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Effect of MYCN Amplification on Tumor Response and Recurrence in Patients With Stage IV Neuroblastoma
Matser, Y. A. H., van Kuilenburg, A. B. P., Samim, A., van Liempt, L. M., van Grotel, M., Kraal, K. C. J. M., Dierselhuis, M. P., van Eijkelenburg, N. K. A., Langenberg, K. P. S., van Noesel, M. M., Molenaar, J., Fiocco, M. & Tytgat, G. A. M., Mar 2026, In: JCO precision oncology. 10, 3Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Relapsed rhabdoid tumours and other non-nephroblastoma childhood and adolescent kidney tumours: perspectives from the HARMONICA collaboration
Ortiz, M. V., Wens, F. S. P. L., Hong, A. L., Quarello, P., Verschuur, A. C., Tracy, E. T., Daw, N. C., Dome, J. S., Walz, A. L., Sprokkerieft, J., Tytgat, G. A. M., Kentsis, A., Libes-Bander, J., Schoettler, P. J., Perotti, D., Drost, J., Venkatramani, R., Geller, J. I. & van den Heuvel-Eibrink, M. M., 2 Jan 2026, (E-pub ahead of print) In: Nature reviews. Urology.Research output: Contribution to journal › Review article › peer-review
1 Citation (Scopus) -
Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine
Langenberg, K. P. S., van Hooff, S. R., Koopmans, B., Strijker, J. G. M., Kholosy, W. M., Ober, K., Zwijnenburg, D. A., van der Hoek, J. J. F., Keller, K. M., Vernooij, L., Schild, L. G., Looze, E. J., Ebus, M. E., Essing, A. H. W., Vree, P. D., Tas, M. L., Matser, Y. A. H., Wienke, J., Volckmann, R. & Tops, B. B. J. & 19 others, , 11 Mar 2025, In: European Journal of Cancer. 218, 115275.Research output: Contribution to journal › Article › peer-review
Open Access9 Citations (Scopus) -
Gain of chromosome 17 is an early genetic abnormality in neuroblastoma with PPM1D emerging as a strong candidate oncogene driving tumor progression
Milosevic, J., Fransson, S., Svensson, J., Otte, J., Olsen, T. K., Sveinbjornsson, B., Hertwig, F., Bartenhagen, C., Abel, F., Reinsbach, S. E., Djos, A., Javanmardi, N., Shi, Y., Hehir-Kwa, J. Y., Mensenkamp, A., Tytgat, G. A., Holmberg, J., Molenaar, J. J., Jongmans, M. & Fischer, M. & 5 others, , 10 Aug 2025, In: Cancer letters. 625, 217769.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Locoregional control in high-risk neuroblastoma using highly-conformal image-guided radiotherapy, with reduced margins and a boost dose for residual lesions
Samim, A., Littooij, A. S., Peters, M., de Keizer, B., van der Steeg, A. F. W., Fajardo, R. D., Kraal, K. C. J. M., Dierselhuis, M. P., van Eijkelenburg, N. K. A., van Grotel, M., Polak, R., van de Ven, C. P., Wijnen, M. H. W. A., Seravalli, E., Willemsen-Bosman, M. E., van Noesel, M. M., Tytgat, G. A. M. & Janssens, G. O., Jan 2025, In: Radiotherapy and Oncology. 202, 110604.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus)